-
Drug alert: Recall of Accusol 35 products
6 Oct 08 | 14.26 | England Northern Ireland Scotland Wales
Baxter Healthcare has recalled a number of batches of Accusol 35 (bicarbonate buffer; Baxter) dialysis solution and Accusol 35 potassium dialysis solution 2mmol/L and 4mmol/L following a reduction in the pH release limit for Accusol 35 products more >
-
PJ letters (4 October 2008)
3 Oct 08 | 23.01 | England EU International Northern Ireland Scotland Wales
Letters published in the 4 October 2008 issue of The Pharmaceutical Journal
more >
-
INR linked to initial haematoma volumes in intracranial haemorrhage
3 Oct 08 | 15.36 | International
Patients with an international normalised ratio (INR) above 3.0, taking warfarin in the lead-up to an intracranial haemorrhage (ICH), have larger initial haematoma volumes, the authors of a new study report (Neurology 2008;71:1084) more >
-
New UK homecare company launched by Celesio
3 Oct 08 | 15.05 | England Northern Ireland Scotland Wales
Celesio, the parent company of AAH Pharmaceuticals, has launched a new UK homecare company, Evolution Homecare more >
-
Recalled product: Ionsys iontophoretic transdermal system
3 Oct 08 | 12.18 | England Scotland Wales
Janssen-Cilag has recalled all Ionsys iontophoretic transdermal system (ITS; fentanyl 40µg) stock irrespective of batch number becausesome units have been found to self-activate, which could cause overdose
more > -
Injectable drug for type 2 diabetes
3 Oct 08 | 11.56 | International
Liraglutide, a once daily injectable treatment for type 2 diabetes, is more effective than once-daily oral glimepiride in decreasing HbA1c levels, systolic blood pressure and weight, according to a study published online
more > -
Phase III data for epilepsy drug
3 Oct 08 | 11.48 | International
Eslicarbazepine acetate (Zebinix), a novel voltage-gated sodium channel blocker, has been shown to be effective, in combination with other antiepileptic drugs, for the treatment of refractory partial epilepsy more >
-
Candesartan may help diabetic retinopathy
3 Oct 08 | 11.44 | International
Candesartan may be of benefit for retinopathy in diabetic patients, the authors of two articles published online. However, they acknowledge that the effects did not reach statistical significance for the primary endpoints
more > -
Welsh strategy launched to tackle drug misuse
2 Oct 08 | 17.19 | Wales
A new 10-year plan for combating drug and alcohol misuse in Wales was launched yesterday (1 October 2008) by Brian Gibbons, the Minister for Social Justice and Local Government more >
-
No justification for using aliskiren first-line, says DTB
2 Oct 08 | 17.04 |
There is no justification for using aliskiren (Rasilez) in preference to effective, long-established alternative treatments for hypertension, according to the October 2008 issue of the Drug and Therapeutics Bulletin
more >
Hello guest, welcome to PJ online
gateway to the world of pharmacy and medicines
